Oliver Gerhard Ottmann Selected Research

Oliver Gerhard Ottmann Research Topics

7	Leukemia 08/2021 - 10/2003
5	Philadelphia Chromosome 08/2021 - 04/2006
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2021 - 04/2006
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2005 - 12/2002
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2021 - 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021
1	Genetic Translocation (Chromosomal Translocation) 12/2002
1	Chronic Granulomatous Disease 08/2002
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2002

4	Phosphotransferases (Kinase)IBA 08/2021 - 04/2006
4	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 10/2003
3	Proteins (Proteins, Gene)FDA Link 04/2015 - 10/2003
2	nilotinib FDA Link 01/2021 - 09/2012
2	Dasatinib (BMS 354825)FDA Link 01/2021 - 09/2012
2	Adenosine Triphosphate (ATP)IBA 04/2015 - 09/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2012 - 10/2003
2	Retinoic Acid Receptor alphaIBA 07/2005 - 05/2004
1	CrizotinibIBA 08/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	ponatinibIBA 01/2021
1	bcr-abl Fusion ProteinsIBA 04/2015
1	Protein Tyrosine PhosphatasesIBA 04/2006
1	Biological ProductsIBA 04/2006
1	Histone Deacetylase InhibitorsIBA 04/2005
1	Hemoglobins (Hemoglobin)IBA 04/2005
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2005
1	Valproic Acid (Depakote)FDA LinkGeneric 04/2005
1	Transcription Factors (Transcription Factor)IBA 12/2002
1	Histones (Histone)IBA 12/2002
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 12/2002
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 08/2002

1	Therapeutics 08/2021